Nutrient pathways and neural tube defects: A semi-bayesian hierarchical analysis

Epidemiology

Volumn 20, Issue 1, 2009, Pages 67-73

  Carmichael, Suzan L ^a,c   Witte, John S ^b   Shaw, Gary M ^a  

^a California Research Division   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUCROSE; XANTHOPHYLL;

ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GLYCEMIC CONTROL; GLYCEMIC INDEX; HUMAN; MAJOR CLINICAL STUDY; METHYLATION; NEURAL TUBE DEFECT; NUTRIENT UPTAKE; OXIDATIVE STRESS; PRIORITY JOURNAL; VITAMIN SUPPLEMENTATION;

BAYES THEOREM; CALIFORNIA; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; FEMALE; FOOD; GLYCEMIC INDEX; HUMANS; INFANT, NEWBORN; INTERVIEWS AS TOPIC; LOGISTIC MODELS; LUTEIN; MEDICAL AUDIT; NEURAL TUBE DEFECTS; PREGNANCY; RISK ASSESSMENT; VITAMINS;

EID: 67651113883     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/EDE.0b013e31818f6375     Document Type: Article

References (57)

1. MRC Vitamin Study Research Group.Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137.
2. Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. New Engl J Med. 1999;341:1485-1490.
3. Berry RJ, Li Z. Folic acid alone prevents neural tube defects: evidence from the China study. Epidemiology. 2002;13:114 -116.
4. Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA. 1989;262:2847-2852.
5. Shaw GM, Schaffer D, Velie EM, et al. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology. 1995;6:219 -226.
6. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA. 1993;269:1257-1261.
7. Shaw GM, Carmichael SL, Yang W, et al. Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol. 2004;160:102-109.
8. Shaw GM, Velie EM, Schaffer DM. Is dietary intake of methionine associated with a reduction in risk for neural tube defect-affected pregnancies? Teratology. 1997;56:295-299.
9. Shoob HD, Sargent RG, Thompson SG, et al. Dietary methionine is involved in the etiology of neural tube defect-affected pregnancies in humans. J Nutr. 2001;131:2653-2658.
10. Ray JG, Wyatt PR, Thompson MD, et al. Vitamin B12 and the risk of neural tube defects in a folic-acid-fortified population. Epidemiology. 2007;18:362-366.
11. Groenen PM, Peer PG, Wevers RA, et al. Maternal myo-inositol, glucose, and zinc status is associated with the risk of offspring with spina bifida. Am J Obstet Gynecol. 2003;189:1713-1719.
12. Shaw GM, Quach T, Nelson V, et al. Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr. 2003;78:972-978.
13. Blom HJ, Shaw GM, den Heijer M, et al. Neural tube defects and folate: case far from closed. Nat Rev Neurosci. 2006;7:724 -731.
14. Steegers-Theunissen RP, Boers GH, Trijbels FJ, et al. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 1994;43:1475-1480.
15. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet. 1995;345:149-151.
16. Zhao W, Mosley BS, Cleves MA, et al. Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolism. Birth Defects Res A Clin Mol Teratol. 2006;76:230 -236.
17. Van Der Put NM, van Straaten HW, Trijbels FJ, et al. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med (Maywood). 2001;226:243-270.
18. Adams MJJr, Khoury MJ, Scanlon KS, et al. Elevated midtrimester serum methylmalonic acid levels as a risk factor for neural tube defects. Teratology. 1995;51:311-317.
19. Ray JG, Blom HJ. Vitamin B12 insufficiency and the risk of fetal neural tube defects. QJM. 2003;96:289 -295.
20. Becerra JE, Khoury MJ, Cordero JF, et al. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics. 1990;85:1-9.
21. Hendricks KA, Nuno OM, Suarez L, et al. Effects of hyperinsulinemia and obesity on risk of neural tube defects among Mexican Americans. Epidemiology. 2001;12:630-635.
22. Groenen PM, Wevers RA, Janssen FS, et al. Are myo-inositol, glucose and zinc concentrations in amniotic fluid of fetuses with spina bifida different from controls? Early Hum Dev. 2003;71:1-8.
23. Friel JK, Frecker M, Fraser FC. Nutritional patterns of mothers of children with neutral tube defects in Newfoundland. Am J Med Genet. 1995;55:195-199.
24. Groenen PM, van Rooij IA, Peer PG, et al. Low maternal dietary intakes of iron, magnesium, and niacin are associated with spina bifida in the offspring. J Nutr. 2004;134:1516 -1522.
25. Martin I, Gibert MJ, Pintos C, et al. Oxidative stress in mothers who have conceived fetus with neural tube defects: the role of aminothiols and selenium. Clin Nutr. 2004;23:507-514.
26. Verma K, Wei KD. Disorders of the developing nervous system of vitamin E-deficient rats. Acta Anat (Basel). 1967;67:623-635.
27. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child. 1976;51:944 -950.
28. Schorah CJ, Wild J, Hartley R, et al. The effect of periconceptional supplementation on blood vitamin concentrations in women at recurrence risk for neural tube defect. Br J Nutr. 1983;49:203-211.
29. Loeken MR. Free radicals and birth defects. J Matern Fetal Neonatal Med. 2004;15:6 -14.
30. Freedman S, Pee D. Return to a note on screening regression equations. Am Stat. 1989;43:279 -282.
31. Witte JS, Greenland S, Haile RW, et al. Hierarchical regression analysis applied to a study of multiple dietary exposures and breast cancer. Epidemiology. 1994;5:612-621.
32. Greenland S. Bayesian perspectives for epidemiological research. II. Regression analysis. Int J Epidemiol. 2007;36:195-202.
33. Hung RJ, Brennan P, Malaveille C, et al. Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2004;13:1013-1021.
34. Croen LA, Shaw GM, Jensvold NJ, et al. Birth defects monitoring in California: a resource for epidemiologic research. Paediatr Perinat Epidemiol. 1991;5:423-427.
35. Block G, Hartman AM, Dresser CM, et al. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453-469.
36. De Roos AJ, Poole C, Teschke K, et al. An application of hierarchical regression in the investigation of multiple paternal occupational exposures and neuroblastoma in offspring. Am J Ind Med. 2001;39:477-486.
37. Shaw GM, Todoroff K, Schaffer D, et al. Periconceptional nutrient intake and risk for neural tube defect-affected pregnancies. Epidemiology. 1999;10:711-716.
38. Granado F, Olmedilla B, Blanco I. Nutritional and clinical relevance of lutein in human health. Br J Nutr. 2003;90:487-502.
39. Velie EM, Block G, Shaw GM, et al. Maternal supplemental and dietary zinc intake and the occurrence of neural tube defects in California. Am J Epidemiol. 1999;150:605-616.
40. Shaw GM, Carmichael SL, Yang W, et al. Periconceptional dietary intake of myo-inositol and neural tube defects in offspring. Birth Defects Res A Clin Mol Teratol. 2005;73:184 -187.
41. Van den Veyver IB. Genetic effects of methylation diets. Annu Rev Nutr. 2002;22:255-282.
42. Fisher MC, Zeisel SH, Mar MH, et al. Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. Teratology. 2001;64:114 -122.
43. McBride WG, Hicks LJ. Acetylcholine and choline levels in rabbit fetuses exposed to anticholinergics. Int J Dev Neurosci. 1987;5:117-125.
44. Aberg A, Westbom L, Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum Dev. 2001;61:85-95.
45. Anderson JL, Waller DK, Canfield MA, et al. Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology. 2005;16:87-92.
46. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA. 1996;275:1093-1096.
47. Shaw GM, Todoroff K, Schaffer DM, et al. Maternal height and prepregnancy body mass index as risk factors for selected congenital anomalies. Paediatr Perinat Epidemiol. 2000;14:234 -239.
48. Werler MM, Louik C, Shapiro S, et al. Prepregnant weight in relation to risk of neural tube defects. JAMA. 1996;275:1089 -1092.
49. Wentzel P, Gareskog M, Eriksson UJ. Folic acid supplementation diminishes diabetes- and glucose-induced dysmorphogenesis in rat embryos in vivo and in vitro. Diabetes. 2005;54:546 -553.
50. Li R, Chase M, Jung SK, et al. Hypoxic stress in diabetic pregnancy contributes to impaired embryo gene expression and defective development by inducing oxidative stress. Am J Physiol Endocrinol Metab. 2005;289:E591-E599.
51. Nakano E, Higgins JA, Powers HJ. Folate protects against oxidative modification of human LDL. Br J Nutr. 2001;86:637-639.
52. Rosenquist TH, Ratashak SA, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci U S A. 1996;93:15227-15232.
53. Joshi R, Adhikari S, Patro BS, et al. Free radical scavenging behavior of folic acid: evidence for possible antioxidant activity. Free Radic Biol Med. 2001;30:1390 -1399.
54. Ho PI, Ashline D, Dhitavat S, et al. Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol Dis. 2003;14:32-42.
55. MacLehose RF, Dunson DB, Herring AH, et al. Bayesian methods for highly correlated exposure data. Epidemiology. 2007;18:199 -207.
56. Greenland S. Methods for epidemiologic analyses of multiple exposures: a review and comparative study of maximum-likelihood, preliminarytesting, and empirical-Bayes regression. Stat Med. 1993;12:717-736.
57. Swan SH, Shaw GM, Shulman J. Reporting and selection bias in case-control studies of congenital malformations. Epidemiology. 1992;3:356-363.